Developmental uterine anomalies in transgender patients receiving gender-affirming hysterectomies

N Nguyen,H Kim,M Sumida,R Galzote
DOI: https://doi.org/10.1016/j.ajog.2024.02.195
IF: 9.8
2024-03-22
American Journal of Obstetrics and Gynecology
Abstract:Most developmental uterine anomalies occur due to Mullerian duct maldevelopment and are often incidentally discovered through pelvic imaging or intraoperatively. The incidence and prevalence of uterine anomalies are well known in the cisgender female general population. A few studies on gender-affirming hysterectomies have reported on the histological endometrial findings of patients using testosterone therapy, with findings of endometrial atrophy ranging from 18 to 50%. 1-3. However, there are no known studies which report developmental uterine anomalies in transgender male or nonbinary (TGNB) patients. Many transgender and nonbinary patients who are assigned female at birth (AFAB) undergo gender affirming bottom surgeries via hysterectomies which may be accompanied by staged phalloplasty.
obstetrics & gynecology
What problem does this paper attempt to address?